Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-VEGF Treatment for Prevention of PDR/DME

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02634333
Recruitment Status : Active, not recruiting
First Posted : December 18, 2015
Last Update Posted : August 24, 2018
Sponsor:
Collaborators:
Regeneron Pharmaceuticals
Juvenile Diabetes Research Foundation
National Eye Institute (NEI)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Jaeb Center for Health Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2020
  Estimated Study Completion Date : January 2022